Kore.ai vs Bland AI

Detailed side-by-side comparison to help you choose the right tool

Kore.ai

🟢No Code

Voice AI Tools

Enterprise conversational AI platform for building intelligent virtual assistants with voice, chat, and process automation capabilities.

Was this helpful?

Starting Price

~$100,000/year

Bland AI

🟡Low Code

Voice AI

Bland AI is an enterprise voice AI platform for building, testing, and running phone agents on a self-hosted stack with sub-second latency and one all-in per-minute rate.

Was this helpful?

Starting Price

Free

Feature Comparison

Scroll horizontally to compare details.

FeatureKore.aiBland AI
CategoryVoice AI ToolsVoice AI
Pricing Plans25 tiers183 tiers
Starting Price~$100,000/yearFree
Key Features
  • Visual Dialog Builder & Conversation Design
  • Voice AI & Contact Center Connectors
  • Pre-Built Industry Solutions
  • Self-Hosted Infrastructure
  • Sub-300ms Global Latency
  • Warm Transfer with Context

💡 Our Take

Choose Kore.ai if you operate a regulated contact center where governance, vertical pre-training, and integration with Genesys or NICE matter more than per-call cost. Choose Bland AI if you need high-volume outbound or inbound phone agents quickly, value transparent per-minute pricing, and can build your own conversation logic rather than relying on enterprise pre-built solutions.

Kore.ai - Pros & Cons

Pros

  • Recognized as a Leader in the Gartner Magic Quadrant for Enterprise Conversational AI Platforms multiple years running
  • Native integration with 6+ major contact center platforms (Genesys, NICE CXone, Avaya, Cisco UCCE, Amazon Connect, Twilio)
  • Pre-built vertical solutions (BankAssist, HealthAssist, AgentAssist, SmartAssist) shorten go-live by months
  • Reported to process 2+ billion interactions annually across 400+ Fortune 2000 customers
  • Supports 100+ languages with on-premise, hybrid, and SaaS deployment options
  • GALE engine adds governed generative AI and RAG without abandoning deterministic dialog flows

Cons

  • No public pricing — every deal goes through sales and procurement
  • Steep learning curve; advanced flows typically require certified developers or partner SI involvement
  • Implementation usually requires a multi-month professional services engagement
  • Smaller open-source community compared to Rasa, LangChain, or Dialogflow ecosystems
  • Proprietary dialog and NLU formats create meaningful vendor lock-in

Bland AI - Pros & Cons

Pros

  • All-in per-minute pricing bundles LLM + STT + TTS in one rate, removing token-based surprise bills and four-vendor invoice math
  • Self-hosted custom voice stack delivers ~400ms latency and a single data-handling boundary that satisfies regulated buyers
  • Deep compliance posture (SOC 2 Type II, HIPAA + BAA, PCI DSS v4.0, GDPR, on-prem/VPC) clears enterprise security review quickly

Cons

  • Many production-grade features (warm/live transfers, guardrails, custom dialing, SSO, BAA, data residency) are gated to Enterprise
  • Cannot bring your own LLM or third-party TTS provider — this is the trade-off for bundled pricing and tight latency
  • Start plan caps at 10 concurrent calls and 100/day, so real production use jumps you straight to the $299/mo Build tier

Not sure which to pick?

🎯 Take our quiz →

🔒 Security & Compliance Comparison

Scroll horizontally to compare details.

Security FeatureKore.aiBland AI
SOC2✅ Yes✅ Yes
GDPR✅ Yes✅ Yes
HIPAA✅ Yes✅ Yes
SSO✅ Yes✅ Yes
Self-Hosted✅ Yes✅ Yes
On-Prem✅ Yes✅ Yes
RBAC✅ Yes✅ Yes
Audit Log
Open Source❌ No❌ No
API Key Auth✅ Yes✅ Yes
Encryption at Rest
Encryption in Transit
Data Residency
Data RetentionCustomer controlled
🦞

New to AI tools?

Read practical guides for choosing and using AI tools

🔔

Price Drop Alerts

Get notified when AI tools lower their prices

Tracking 2 tools

We only email when prices actually change. No spam, ever.

Get weekly AI agent tool insights

Comparisons, new tool launches, and expert recommendations delivered to your inbox.

No spam. Unsubscribe anytime.

Ready to Choose?

Read the full reviews to make an informed decision